| 项目编号 |
PRJCA014383 |
| 项目标题 |
A Randomized, Double-blind, PlaceboControlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients with ES-SCLC |
| 涉及领域 |
Medical |
| 数据类型 |
PK and ADA and PD-L1 and MSITMB
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
PK and ADA samples of HLX10 or placebo are collected and sent to the central laboratory for evaluation. PK and ADA samples for HLX10 or placebo will be collected at the following time points:Within 7 days pre-dose in Cycle 1, within 3 days pre-dose in Cycles 2,4,6,8 and every 4 cycles thereafter,within 2 hours after the end of dosing in Cycles 1 and 8 of treatment period(for PK only),and at EOT visit and safety follow-up. |
| 样品范围 |
Multiisolate |
| 发布日期 |
2023-01-12 |
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| No funding support
|
|
|
|
|
|
| 提交者 |
zhao
nan (1165095416@qq.com)
|
| 提交单位 |
Jilin Cancer Hospital |
| 提交日期 |
2023-01-12 |
